ARNA Related Company Press Releases
-
BELVIQ® (lorcaserin HCl) CIV Data to be Presented at ENDO 2013
-
Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
-
Arena Pharmaceuticals Reports on Launch of BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
-
Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
-
Art Pappas Elected to NVCA Board of Directors
-
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
-
Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management
-
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
-
Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
Back to ARNA Stock Lookup
